1776 Wealth’s Antares Pharma, Inc. ATRS Stock Holding History

1776 Wealth’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,000	Closed	-$57K	–	134
2022 Q1	$57K	Hold	14,000	–	–	0.03%	128
2021 Q4	$50K	Hold	14,000	–	–	0.03%	124
2021 Q3	$51K	Hold	14,000	–	–	0.03%	117
2021 Q2	$61K	Hold	14,000	–	–	0.03%	117
2021 Q1	$58K	Hold	14,000	–	–	0.04%	112
2020 Q4	$56K	Hold	14,000	–	–	0.04%	114
2020 Q3	$38K	Hold	14,000	–	–	0.03%	108
2020 Q2	$38K	Sell	14,000 -10,000	-42%	-$27.9K	0.03%	205
2020 Q1	$84K	Buy	24,000 +12,000	+100%	+$40.8K	0.04%	190
2019 Q4	$56K	Buy	+12,000	New	+$49.1K	0.05%	177

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

1776 Wealth's ATRS Position: Q2 2022 in Review

1776 Wealth sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 14,000 shares — an estimated $57K sold.

1776 Wealth first reported a position in ATRS in Q4 2019 and held it in 10 quarters. The position peaked at $84K in Q1 2020. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

1776 Wealth reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
1776 Wealth sold 14,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $57K.
1776 Wealth first reported a position in Antares Pharma, Inc. in Q4 2019 and held it in 10 quarters.
1776 Wealth's Antares Pharma, Inc. position peaked at $84K in Q1 2020.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on 1776 Wealth's 13F filing for Q2 2022, filed 29 Jul 2022.